DNA X
SONM | NASDAQ
$2.10
-$0.07 (-3.23%)
At close: Nov 16, 2026, 4:00 PM ET
$2.12
+$0.02 (+0.95%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-3.23%
(1D)No price chart data available for 1D timeframe.
Rating
32.5
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #695/817 (Top 85%)
Key Statistics
Market Data
Market Cap $3.13M
1D Range
2.03 2.32
52W Range
2.03 9.59
Valuation (TTM)
PE -
PB -2.54
EV/EBITDA -1.84
Valuation (NTM)
Forward PE 0.11
Forward PEG -0.05
Price Target $0.00
Cash Flow
FCF Yield -466.5%
SBC Adj. FCF Yield -440.5%
SBC Impact -5.6%
Margins
Gross Margin 48.4%
Operating Margin 15.1%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -146.8% |
-40.9%
Dil EPS 3Y | 5Y 46.5% |
68.2%
FCF 3Y | 5Y -40.2% |
8.7%
Returns
ROA -189.2%
ROE 391.0%
ROIC -228.3%
Financial Health
Net Debt
$1.5M
Current Ratio 0.57
Interest Coverage -3.30
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in deliv...
Sector Technology
Industry Communication Equipment
Employees 4
IPO Date May 10, 2019
Website ir.dna-x.global
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SONM